| Name | Necrosulfonamide |
|---|---|
| Synonyms |
(2E)-N-[4-[[(3-Methoxy-2-pyrazinyl)amino]sulfonyl]phenyl]-3-(5-nitro-2-thienyl)-2-propenamide
(E)-N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide necrosulfonamide 2-Propenamide, N-[4-[[(3-methoxy-2-pyrazinyl)amino]sulfonyl]phenyl]-3-(5-nitro-2-thienyl)-, (2E) (2E)-N-{4-[(3-Methoxy-2-pyrazinyl)sulfamoyl]phenyl}-3-(5-nitro-2-thienyl)acrylamide CHEBI:63770 NecrosulfonaMide formation,necrosis,necrosome,substrate,RIP3,Inhibitor,inhibit,complex,Necrosulfonamide,Mixed Lineage Kinase,MLKs (2Z)-N-{4-[(3-Methoxy-2-pyrazinyl)sulfamoyl]phenyl}-3-(5-nitro-2-thienyl)acrylamide (Z)-Necrosulfonamide Necrosulfonamide (NSA) (E)-N-(4-(N-(3-Methoxypyrazin-2-yl)sulfaMoyl)phenyl)-3-(5-nitrothiophen-2-yl)acrylaMide (2E)-N-{4-[(3-methoxypyrazin-2-yl)sulfamoyl]phenyl}-3-(5-nitrothiophen-2-yl)prop-2-enamide (E)-NECROSULFONAMIDE Necrosulfonamide, 10 mM in DMSO |
| Description | Necrosulfonamide is a necroptosis inhibitor acting by selectively targeting the mixed lineage kinase domain-like protein (MLKL) to block the necrosome formation. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Melting Point | 257 °C(dec.) |
| Molecular Formula | C18H15N5O6S2 |
| Molecular Weight | 461.472 |
| Exact Mass | 461.046387 |
| LogP | 4.08 |
| Index of Refraction | 1.695 |